SIRT1 and neoplasm: In orthopedic tumor xenograft mice model with HepG2 hepatocarcinoma cells, Cambinol significantly reduced tumor growth, which was consistent with the SIRT1 knockdown results of in vivo intrahepatic xenograft mouse model (Portmann et al., 2013).